Monitoring the quality of SARS-CoV-2 virus detection in molecular diagnostic laboratories in the Eastern Mediterranean Region during the COVID-19 pandemic

被引:3
作者
Meredith, Luke W. [1 ]
Aboualy, Mustafa [1 ]
Ochola, Rachel [1 ]
Ozel, Mehmet [1 ]
Abubakar, Abdinasir [1 ]
Barakat, Amal [1 ]
机构
[1] WHO, Eastern Mediterranean Reg Off, Dept Hlth Emergency, Infect Hazard Management, Cairo, Egypt
关键词
COVID-19; EMRO; laboratory; quality; SARS-CoV-2; surveillance;
D O I
10.1111/irv.13217
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Introduction: The COVID-19 pandemic placed unprecedented stress on laboratories in the Eastern Mediterranean Region. Building on existing capacity for influenza diagnostics, countries introduced COVID-19 diagnostic support to similar to 100% regional coverage. A key challenge during the expansion was maintaining quality testing in laboratories, ensuring that correct results were shared with medical facilities. Methods: WHO organized two rounds of independently monitored severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) external quality assurance programs (EQAP). The Public Health Laboratory (PHL) division of WHO supplied external quality assurance (EQA) panels, from the Royal College of Pathologists of Australasia Quality Assurance Programme (RCPAQAP) Australia to laboratories not enrolled in recurring Global Influenza Surveillance and Response System (GISRS) quality assurance programs, in which national influenza centers routinely participate. Results: Fifteen and 14 countries participated in PHL/EQAP for SARS-CoV-2 between 2020 and 2022. Concordance was consistent between rounds, reaching 96.4% and 89.9%. A separate assessment of GISRS/EQAP to national-level laboratories identified high levels of response and concordance for SARS-CoV-2 (100% response, 93% concordance), which was reduced for influenza (50% response rate, 80% concordance), reflecting the challenge of prioritizing pathogens during outbreaks. Conclusion: The proliferation of laboratories in response to COVID-19 was a success story from the pandemic. However, monitoring the quality of laboratories was challenging via existing EQAP. The addition of PHL/EQAP provided a mechanism to monitor performance of laboratories that were not designated as national influenza centers. While a high proportion of laboratories attained good results, continual emphasis on quality and enrollment in EQAP is key to ensuring sustainability of laboratory testing in future.
引用
收藏
页数:8
相关论文
共 24 条
  • [11] Enhanced surveillance of monkeypox in Bas-Uele, Democratic Republic of Congo: the limitations of symptom-based case definitions
    Mande, Gaspard
    Akonda, Innocent
    De Weggheleire, Anja
    Brosius, Isabel
    Liesenborghs, Laurens
    Bottieau, Emmanuel
    Ross, Noam
    Gembu, Guy-Crispin
    Colebunders, Robert
    Verheyen, Erik
    Ngonda, Dauly
    Leirs, Herwig
    Laudisoit, Anne
    [J]. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2022, 122 : 647 - 655
  • [12] Adaptive, diverse and de-centralized diagnostics are key to the future of outbreak response
    Matthews, Quinn
    da Silva, Severino Jefferson Ribeiro
    Norouzi, Masoud
    Pena, Lindomar Jose
    Pardee, Keith
    [J]. BMC BIOLOGY, 2020, 18 (01)
  • [13] Danger ahead: the burden of diseases, injuries, and risk factors in the Eastern Mediterranean Region, 1990-2015
    Mokdad, Ali H.
    El Bcheraoui, Charbel
    Charara, Raghid
    Khalil, Ibrahim
    Moradi-Lakeh, Maziar
    Afshin, Ashkan
    Collison, Michael
    Daoud, Farah
    Krohn, Kristopher J.
    Chew, Adrienne
    Biryukov, Stan
    Casey, Daniel
    Cercy, Kelly
    Charlson, Fiona J.
    Cornaby, Leslie
    Dicker, Daniel
    Erskine, Holly E.
    Ferrari, Alize J.
    Fitzmaurice, Christina
    Foreman, Kyle J.
    Fraser, Maya
    Frostad, Joseph
    Godwin, William W.
    Griswold, Max
    Kassebaum, Nicholas J.
    Kemmer, Laura
    Kutz, Michael
    Kyu, Hmwe H.
    Leung, Janni
    Liu, Patrick
    Mikesell, Joseph
    Nguyen, Grant
    Olsen, Helen E.
    Reiner, Robert
    Reitsma, Marissa
    Roth, Gregory
    Santomauro, Damian
    Smith, Alison
    Stanaway, Jeffrey D.
    Sur, Patrick
    Wang, Haidong
    Whiteford, Harvey A.
    Afifi, Rima
    Kiadaliri, Aliasghar Ahmad
    Ahmadi, Alireza
    Ahmadieh, Hamid
    Alam, Khurshid
    Alam, Noore
    Ali, Raghib
    Alizadeh-Navaei, Reza
    [J]. INTERNATIONAL JOURNAL OF PUBLIC HEALTH, 2018, 63 : 11 - 23
  • [14] Morales M., 2021, COVID19 tests gone rogue: privacy, efficacy, mismanagement and misunderstandings
  • [15] Decentralization of COVID-19 molecular diagnosis, a success story from Jordan
    Qaqish, Arwa
    Al-Omari, Mariam
    Abbas, Manal M.
    Said, Rana
    Al Tamimi, Mohammad
    Ghazo, Mahmoud
    [J]. JOURNAL OF GLOBAL HEALTH, 2022, 12
  • [16] qcmd, Quality Control for Molecular Diagnostics
  • [17] Rockefeller Foundation, 2020, A landscape analysis of laboratory technologies for Covid19 response in lowand middleincome countries
  • [18] US faces triple epidemic of flu, RSV, and covid
    Tanne, Janice Hopkins
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2022, 379
  • [19] Considerations for diagnostic COVID-19 tests
    Vandenberg, Olivier
    Martiny, Delphine
    Rochas, Olivier
    van Belkum, Alex
    Kozlakidis, Zisis
    [J]. NATURE REVIEWS MICROBIOLOGY, 2021, 19 (03) : 171 - 183
  • [20] WHO, 2022, WHO EMRO Regional Countries